Bio-Pulsed Embryonic MSC Exosomes:distinguishing science from noise.
When the message matters more than the envelope.
EXOSOMES: THE MOST MISUNDERSTOOD WORD IN MODERN AESTHETICS
'Everyone talks about them. Few know what they are.
And the distance between talking and knowing, in biology, is not a detail:
it is the difference between science and marketing.'
'Exosomes' has become the magic word of contemporary aesthetics. Every serum, every treatment, every brochure seems to contain them. But like every word that is overused and poorly understood, it has lost its meaning. And when a word loses its meaning, it becomes a slogan.
This document exists to restore that meaning.
The market is flooded with products that claim 'contains exosomes' without explaining what they are, where they come from, or what they carry. It is like selling a book by saying 'contains words' — technically true, scientifically irrelevant. Which words? In which language? With which meaning?
The confusion is not accidental. It serves those who have nothing to prove. Because the moment one clarifies what an exosome truly is, what it must contain, where it must come from and with what evidence — the majority of products currently on the market leave the playing field.
This document is written for those who wish to understand before choosing. For those who know that the difference between a professional and a salesperson is the ability to explain what they are proposing. |
— ✦ —
WHAT EXOSOMES TRULY ARE
Scientific definition: MISEV2023
According to the MISEV2023 guidelines (Minimal Information for Studies of Extracellular Vesicles), an exosome is an extracellular vesicle ranging from 30 to 150 nanometres in diameter, originating from the cell’s multivesicular body (MVB) and released into the extracellular space via exocytosis. It is not a random cellular fragment. It is not debris. It is an intentional communication system — a biological structure designed by the cell to transport precise information to specific recipients.
The structure is sophisticated: a lipid bilayer that protects the internal cargo — miRNA, mRNA, proteins, bioactive lipids — and a surface decorated with transmembrane proteins that serve as a recognition and targeting system.
Tetraspanins: the exosome’s identity card
The key proteins on the exosome’s surface are the tetraspanins CD9, CD63 and CD81. These are not a technical detail — they are the defining criterion according to MISEV2023 for distinguishing an exosome from any other extracellular vesicle.
Tetraspanins are like a vehicle’s registration plate.
Without a plate, a vehicle exists physically — but it is not identifiable,
not authorised, and has no certified origin.
Anyone selling you a vehicle without a plate is selling you something unidentified.
The bottom line Without documented CD9/CD63/CD81 tetraspanins, an extracellular vesicle is NOT an exosome by international definition (MISEV2023). Full stop. It is like calling any sparkling wine 'champagne': the word alone is not sufficient without the origin and certification to support it. |
— ✦ —
NOT ALL MESSAGES REACH THEIR DESTINATION
An exosome is a biological postal system. But for a message to arrive and actually be read by the recipient cell, three conditions must be met simultaneously:
1. The right sender — who writes the message. An embryonic mesenchymal stem cell produces regenerative instructions. A plant produces instructions for plant defence. Bovine colostrum produces instructions for neonatal calf immunity.
2. The right envelope — recognisable by the recipient. The tetraspanins CD9/CD63/CD81 are the biological postcode. Without them, the human cell does not recognise the envelope and does not open it.
3. The right message — written in the recipient’s language. The miRNAs must have genetic targets conserved across vertebrate evolution. A plant miRNA targets plant genes — the human cell does not possess those genes.
If even one of these three conditions is missing, the 'message' does not arrive.
It is like posting a letter in Chinese, to a non-existent address,
in an envelope without a stamp.
The letter exists physically — but it communicates nothing.
Three sources, three entirely different biological realities
Embryonic MSC Exosomes — the right message ✓ Origin: embryonic mesenchymal stem cells (maximum biological plasticity) ✓ Tetraspanins: CD9, CD63, CD81 documented — true exosomal identity ✓ Cargo: miRNA with genetic targets conserved across vertebrates (Wnt, TGF-β, FGF) ✓ Effect: fibroblast activation, neocollagenesis, ECM remodelling, anti-senescence ✓ Evidence: peer-reviewed in vitro and clinical studies (Shieh et al. 2022, 2025) |
Plant 'exosomes' (PDEVs) — the wrong message ✗ Origin: plant cells — biology of the Plantae kingdom ✗ Tetraspanins: ABSENT — not exosomes by MISEV2023 definition ✗ Cargo: miRNA targeting plant genes — human cells do not possess those genes ✗ Effect: no documented activation of human regenerative pathways ✗ Correct term: Plant-Derived Extracellular Vesicles (PDEVs) |
Colostrum vesicles — the wrong message for the wrong recipient ✗ Origin: bovine post-partum glandular secretion ✗ Original biological purpose: transferring passive immunity to the newborn calf ✗ Cargo: immunomodulatory miRNA — not regenerative for human skin ✗ Effect: no evidence of fibroblast activation or cutaneous neocollagenesis ✗ 'Biologically active' ≠ 'regenerative' — a good anti-inflammatory is not a surgeon |
This distinction is not an opinion — it is physiology. And conflating these three realities under a single commercial term is a disservice to both the professional and the patient.
— ✦ —
THE EMBRYO: THE MOST ACTIVE BIOLOGICAL BUILDING SITE IN EXISTENCE
Why the embryonic phase? Because it is the only biological moment in which all regenerative pathways are co-activated simultaneously. Wnt, TGF-β, FGF — the three pillars of tissue regeneration — work together, at the same time, to build an entire organism from scratch.
The embryo is a building site where ALL departments work simultaneously:
structural construction (Wnt), tissue architecture (TGF-β), vascular services (FGF).
The instructions that emerge from this site are the most complete
that biology knows. No adult tissue produces cargo this rich.
Adult mesenchymal stem cells — those from adipose tissue, bone marrow, or the umbilical cord — do produce exosomes. But their cargo reflects the biological phase of origin: these are cells that have already chosen their trajectory. Embryonic MSCs have not yet chosen anything — everything is switched on. And this difference is directly reflected in the richness and completeness of the exosomal cargo.
Bio-Pulsation: enriching the cargo before dispatch
Bio-Pulsation technology adds a second level of sophistication. The embryonic MSC cells are stimulated under controlled conditions before vesicle extraction. This stimulation — a proprietary calibrated mechanical stress protocol — induces the cell to produce exosomes with a significantly higher regenerative miRNA payload compared to passive extraction.
It is like asking an expert to write their best instructions
at the very moment when they are most focused and motivated.
The result is a richer, more precise, more effective message.
In vitro data (Shieh et al. 2022) confirm that Bio-Pulsed exosomes exhibit significant enrichment in key miRNAs compared to passively extracted exosomes, with measurable effects on fibroblast proliferation and collagen gene expression.
— ✦ —
BUSTING THE MYTHS — THE FALSE FEARS THAT BLOCK UNDERSTANDING
In the world of professional aesthetics, fears and misunderstandings about exosomes circulate that deserve clear answers. Not commercial answers — physiological ones.
MYTH: 'But they come from chicken! Isn’t that unnatural?' REALITY: This is not xenotransplantation — it is inter-species molecular signalling based on evolutionarily conserved sequences. Aves and mammals share the same embryonic pathways (Wnt, TGF-β, FGF) through evolutionary conservation in amniote vertebrates. Human ribosomes recognise and translate the instructions contained in avian embryonic mRNA because the biological code is the same. It is the biological phase (embryonic) that matters, not the species. |
MYTH: 'Epigenetics modifies DNA! Isn’t that dangerous?' REALITY: NO. Epigenetics modulates WHICH genes are expressed; it does not modify the DNA sequence. miRNAs bind to mRNA and regulate protein translation — they never touch the DNA. It is like a dimmer switch: it does not change the light bulb, it changes how much light it emits. No genetic modification, no risk of permanent alteration. |
MYTH: 'Plant exosomes are more natural and therefore better.' REALITY: Plant-derived EVs contain miRNA whose targets are plant genes. Human cells do not possess those genes. It is like sending an order written in a language that nobody in the company understands: the order arrives physically, but nobody carries it out. 'Natural' does not mean 'compatible'. Cellulose is perfectly natural — yet your enzymes cannot digest it, because you are simply not equipped to do so. |
MYTH: 'If they are so powerful, aren’t they dangerous?' REALITY: Exosomes operate through physiological mechanisms — they modulate, they do not force. They are not drugs, they are not gene therapy. They are the way cells NATURALLY communicate with one another at every moment of life. Applying MSC exosomes is like strengthening a postal system that already exists, not introducing a mechanism foreign to the organism. |
MYTH: 'They’re all the same anyway — they contain exosomes.' REALITY: Without documented CD9/CD63/CD81 tetraspanins, they are not exosomes by MISEV2023 definition. It is like calling any sparkling wine 'champagne': the word is the same, but the origin, the process and the content are entirely different. The professional who fails to make this distinction puts their own credibility at risk. |
— ✦ —
EPIGENETICS: THE NEW FRONTIER THAT SHOULD NOT FRIGHTEN
What epigenetics is — in plain terms
Every cell in the human body contains the same DNA — the same complete book of instructions. And yet a fibroblast does entirely different things from a neurone. Why? Because not all chapters of the book are open at the same time. Epigenetics is the system that determines which chapters to read at any given moment.
Imagine DNA as a vast library. Every cell has the same library.
But not all the books are on the reading table. Epigenetics decides
which books to open, which to close, which to re-read.
miRNAs are the silent librarians — they move the books without rewriting them.
This is the fundamental distinction the professional must understand: epigenetics does not modify DNA. It does not rewrite the book. It changes what is being read. And this makes it modulable, reversible and physiological — not a genetic intervention, but a remodulation of expression.
Why this is a revolution
For decades, cosmetology has operated on three levels:
1. The surface — hydrating, protecting, smoothing — classical cosmetics
2. The receptor — biomimetic peptides that 'knock on the cell’s door' and activate intracellular signalling cascades
3. The functional epidermis — alpha-hydroxy acids, retinoids — turnover stimulation
Exosomes carrying miRNA open a fourth level — the first capable of entering the cell and directly remodulating gene expression. They do not knock on the door. They do not speak through the intercom. They enter the room and reorganise the library.
The paradigm shift For the first time in the history of professional cosmetology, it is possible to send precise molecular instructions — miRNA — that tell the fibroblast: produce more collagen, reduce inflammation, do not enter senescence. This is not non-specific stimulation. It is not 'activate everything'. It is a targeted message, with a specific recipient and a precise instruction. This is the difference between shouting in a crowded square and whispering in the right ear. |
The four miRNAs: the instructions in the message
The exosomal cargo of Bio-Pulsed Embryonic MSC exosomes contains a characterised miRNA profile, of which four have a documented role in cutaneous regeneration:
miR-21-5p — the anti-inflammatory instruction Function: suppresses pro-inflammatory mediators (IL-6, TNF-α) and directly stimulates dermal fibroblast proliferation. Effect: reduces chronic low-grade inflammation (inflammaging) that accelerates skin ageing, whilst simultaneously activating quiescent fibroblasts. |
miR-181a-5p — the instruction for neocollagenesis Function: activates the TGF-β → collagen type I and type III synthesis pathway. Effect: induces the production of new structural collagen — not the fragmented collagen of cicatricial repair, but organised collagen with architectural function. |
miR-199a-5p — the instruction for remodelling Function: extracellular matrix (ECM) remodelling and pigmentation modulation. Effect: reorganises the tissue architecture and contributes to skin tone uniformity — acting on the cause, not on the visible effect. |
miR-125b — the anti-senescence instruction Function: counteracts fibroblast entry into senescence. Effect: prolongs the vitality and functionality of dermal cells, slowing the transition from active to senescent state (SASP) — the true driver of skin ageing. |
— ✦ —
PEPTIDES + EXOSOMES: TWO LANGUAGES, ONE CONVERSATION
The formulative choice behind ExoHyal is not accidental. The professional line products do not contain merely exosomes — they contain exosomes in synergy with specific biomimetic peptides. This combination is not an addition. It is a convergence — and the difference is biologically fundamental.
Two regulatory levels, one and the same target
Biomimetic peptides work from outside the cell: they bind to membrane receptors and activate intracellular signalling cascades. They are the intercom — speaking to the cell through the door, without entering.
Exosomal miRNAs work from the inside: they enter the cell, reach the mRNA translation machinery and directly modulate which proteins are produced. They are inside the control room, reorganising the operational instructions.
It is not like having two workers doing the same job.
It is like having an architect who designs from the outside
and a structural engineer who reinforces the foundations from within.
Two different competencies converging on the same objective.
When you hit the same biological target from two different regulatory levels — receptor-mediated and post-transcriptional — the result is not additive. It is synergistic: the combined effect exceeds the sum of its parts. The cell receives the same message from two independent channels, and the response is amplified.
The concrete example: convergence on TGF-β
In the ExoHyal Strong protocol, this convergence is clearly visible:
→ SH-Polypeptide-5 (TGF-β3 like) binds to the TGF-β receptor on the fibroblast membrane and activates the signalling cascade from the outside.
→ miR-181a-5p (within the exosomal cargo) enters the fibroblast and activates the TGF-β pathway from the inside, directly modulating collagen I and III gene expression.
Result: convergence on neocollagenesis from two simultaneous directions. The receptor says 'activate'. The miRNA says 'produce'. The cell is left in no doubt about what to do.
The formulative logic of ExoHyal XL Strong SH-Oligopeptide-4 (Thymosin β4 like) → cell migration, neoangiogenesis, matrix reorganisation SH-Oligopeptide-2 (IGF-1 like) → PI3K/Akt/mTOR pathway activation, stem cell stimulation, anagen phase Copper Tripeptide-1 (GHK-Cu) → collagen, elastin, GAGs synthesis, antioxidant and anti-glycation action Bio-Pulsed MSC Exosomes → miRNA modulating the same pathways from within the cell
A multi-peptide + exosomal system targeting cutaneous and follicular regeneration across multiple regulatory levels simultaneously. |
— ✦ —
THE EVIDENCE — DATA, NOT PROMISES
Science is not an opinion. It is not a brochure. It is a method for measuring what actually happens — and accepting the results, even when they do not confirm expectations. The data that follow come from studies published in peer-reviewed scientific journals.
In vitro study — Shieh et al. 2022
Publication: International Journal of Molecular Sciences, 23, 15010.
Results on human dermal fibroblasts treated with Bio-Pulsed MSC exosomes:
→ Significant increase in fibroblast proliferation
→ Accelerated wound closure (wound healing assay)
→ Up-regulation of COL1A1 (collagen type I gene)
→ Up-regulation of COL3A1 (collagen type III gene)
→ Up-regulation of ELN (elastin gene)
→ Reduction of the inflammatory response in fibroblasts
Clinical study — Shieh et al. 2025
Publication: Current Issues in Molecular Biology, 47, 539. Clinical study on 30 subjects (n=30), approved by the Ethics Committee (NCKU no. 113-182-2).
Cutaneous results — 28 days Dermal density (ultrasonographic): +18.2% Skin elasticity: +14.0% Wrinkle depth: −7.5% Pore size: −8.5% Melanin: −6.5% Skin luminosity: +12.3% |
Hair follicle results — 60 days Anagen/Telogen ratio: +48.7% Hair shedding: −46.5% |
— ✦ —
SCIENTIFIC NOTE
Bibliographic references cited in this document:
1. Welsh JA et al. 'MISEV2023: Minimal Information for Studies of Extracellular Vesicles 2023.' Journal of Extracellular Vesicles, 2024; 13: e12404.
2. Shieh JS et al. 'Bio-Pulsed Stimulation Significantly Enhances the Biological Properties of Avian Mesenchymal Stem Cell-Derived Extracellular Vesicles.' Int J Mol Sci, 2022; 23: 15010.
3. Shieh JS et al. 'Topical Application of Bio-Pulsed Avian Mesenchymal Stem Cell-Derived Extracellular Vesicles Significantly Enhances Hair Regrowth and Skin Rejuvenation in Humans.' Curr Issues Mol Biol, 2025; 47: 539.
4. Kalluri R, LeBleu VS. 'The biology, function, and biomedical applications of exosomes.' Science, 2020; 367(6478): eaau6977.
5. Andreu Z, Yáñez-Mó M. 'Tetraspanins in Extracellular Vesicle Formation and Function.' Frontiers in Immunology, 2014; 5: 442.
6. Yáñez-Mó M et al. 'Biological properties of extracellular vesicles and their physiological functions.' Journal of Extracellular Vesicles, 2015; 4: 27066.
7. Théry C et al. 'MISEV2018: a position statement of the International Society for Extracellular Vesicles.' Journal of Extracellular Vesicles, 2018; 7(1): 1535750.
8. Bartel DP. 'MicroRNAs: Target Recognition and Regulatory Functions.' Cell, 2009; 136(2): 215–233.
9. Rutter BD, Innes RW. 'Extracellular Vesicles as Key Mediators of Plant–Microbe Interactions.' Current Opinion in Plant Biology, 2018; 44: 16–22.
10. Liang Y et al. 'Engineering exosomes for targeted drug delivery.' Theranostics, 2021; 11(7): 3183–3195.
11. González MI, Falcón-Pérez JM. 'Cell-derived extracellular vesicles as a platform to identify biomarkers.' J Extracell Biology, 2023; 2: e67.
NATINUEL — ExoHyal
Science in the service of cutaneous physiology.
It is not the envelope that makes the difference.
It is the message it contains.
Comments